Loading stock data…
$3.07+0.11 (+3.72%)
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products.
PMGC Holdings Inc. in the Healthcare sector is trading at $3.07 with a market capitalization of $3M. The stock is currently near its 52-week low of $2.58, remaining 94.4% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 21 is oversold, raising the odds of a near-term bounce. The Whystock Score of 40/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.31M↑ | $681,994↑ | $304,136↑ | $285,948 | $0 |
| Gross Profit | $385,691↑ | $230,474↑ | $107,284↑ | $78,030 | $0 |
| Operating Income | -$3.82M↓ | -$3.32M↓ | -$2.41M↓ | -$2.19M↓ | -$1.01M |
| Net Income | -$2.94M↑ | -$4.97M↓ | -$2.98M↓ | -$2.59M↓ | -$562,355 |
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precisio...